Spiral Strapping for Improving Upper Limb Functions
Stroke, Splints, Physical Disability
About this trial
This is an interventional treatment trial for Stroke focused on measuring Stroke, Upper Limb Functions, Spiral Strapping
Eligibility Criteria
Inclusion Criteria: The inclusion criteria were as follow: Participants were diagnosed as chronic stroke patients. Participants were selected to be in the spastic phase. The degree of spasticity in the affected upper limbs, was ranged between grades (1, 1+&2) according to Modified Ashworth Scale. Participants were all between 50 and 60 years old, of both sexes. Participants were cognitively able to understand and follow instructions. Participants had the ability to extend their wrist joints at least 20° and fingers 10° from full flexion. This range allowed participants to engage easily in performing a designed functional program. Exclusion Criteria: The exclusion criteria were as follow: Participants who were with any orthopedic condition or fixed deformity that interfere with the upper limb functions. Participants who were with spasticity of more than score 2 according to the Modified Ashworth Scale. Participants who had cognitive or perceptual problems. Participants with seizures, visual impairments, or auditory problems. Participants who had shoulder pain on a visual analogue scale of > 6/10. Participants who had Botulinum Toxin in the upper extremity musculature six months before baseline assessment.
Sites / Locations
- Ehab Mohamed Abd El KafyRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Control Group
Experimental Group
Individuals who will participate in the control group will receive a traditional functional exercise training protocol (conventional physiotherapy program) for one hour. It will focus on the enhancement of muscle strength, joint range of motion, arm &hand activities, and daily living functions of the affected upper limbs. The treatment, for the control group, will be conducted over a period of 4 successive weeks, with 3 sessions per week.
Participants in the experimental group will receive the conventional treatment program similar to that will be provided to the control group. The treatment, for the experimental group, will be conducted over a period of 4 successive weeks, with 3 sessions per week. Moreover, they will ¬wear an upper limb spiral strapping system with a hand splint 8 hours daily/ 6 days per week.